Evolutionary Design of a DDPD Model of Ligation. - Mark A. Bedau; Andrew Buchanan; Gianluca Gazzola; Martin M. Hanczyc; Thomas Maeke; John S. McCaskill; Irene Poli; Norman H. Packard (Artificial Evolution, 2005)

Catalysis by Self-Assembled Structures in Emergent Reaction Networks. - Gianluca Gazzola; Andrew Buchanan; Norman H. Packard; Mark A. Bedau (ECAL, 2007)

Predicting user behavior - the creation of the immersion installation. - Andrew Buchanan (Comput. Entertain., 2008)

Darwinian Evolution of Culture as Reflected in Patent Records. - Andrew Buchanan; Norman H. Packard; Mark A. Bedau (ALIFE, 2010)

Evidence in the patent record for the evolution of technology using citation and PageRank statistics. - Mark A. Bedau; Andrew Buchanan; Devin W. Chalmers; C. Cooper Francis; Norman H. Packard; Noah M. Pepper (ECAL, 2011)

Measuring the Evolution of the Drivers of Technological Innovation in the Patent Record. - Andrew Buchanan; Norman H. Packard; Mark A. Bedau (Artif. Life, 2011)

Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design. - Daniel A. Cannon; Lu Shan; Qun Du; Lena Shirinian; Keith W. Rickert; Kim L. Rosenthal; Martin Korade III; Lilian E. van Vlerken-Ysla; Andrew Buchanan; Tristan J. Vaughan; Melissa M. Damschroder; Bojana Popovic (PLoS Comput. Biol., 2019)

DLAB: deep learning methods for structure-based virtual screening of antibodies. - Constantin Schneider; Andrew Buchanan; Bruck Taddese; Charlotte M. Deane (Bioinform., 2022)

Best practices for machine learning in antibody discovery and development. - Leonard Wossnig; Norbert Furtmann; Andrew Buchanan; Sandeep Kumar; Victor Greiff (CoRR, 2023)

LAP: Liability Antibody Profiler by sequence & structural mapping of natural and therapeutic antibodies. - Tadeusz Satlawa; Mateusz Tarkowski; Sonia Wróbel; Pawel Dudzic; Tomasz Gawlowski; Tomasz Klaus; Marek Orlowski; Anna Kostyn; Sandeep Kumar; Andrew Buchanan; Konrad Krawczyk (PLoS Comput. Biol., 2024)